Abstract
MUC4 mucin is a high molecular weight transmembrane glycoprotein that plays important roles in tumour biology. It is aberrantly expressed in pancreatic adenocarcinoma, while not being detectable in the normal pancreas. Previous studies have demonstrated that the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel that is defective in CF, is implicated in multiple cellular functions, including gene regulation. In the present study, using a CFTR-defective pancreatic cancer cell line and its derived subline expressing functional CFTR, we report that MUC4 expression is negatively regulated by CFTR. Short-interfering RNA (siRNA)-mediated silencing of CFTR also leads to an increased expression of MUC4. Additionally, our results suggest that CFTR-mediated regulation of MUC4 is cell density-dependent and is achieved by transcriptional and posttranslational mechanisms. Moreover, in a panel of pancreatic cancer cell lines and normal pancreas, we observed that CFTR was downregulated in pancreatic cancer cells and negatively correlated with MUC4 in most cases. An aberrant expression of MUC4 was also detected in the CF pancreas. Downregulation of CFTR in pancreatic adenocarcinoma and its inverse association with the tumour-linked mucin, MUC4, indicate novel function(s) of CFTR in pancreatic tumour biology and suggest the implication of new signalling pathway(s) in MUC4 regulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Abbreviations
- CF:
-
cystic fibrosis
- CFTR:
-
cystic fibrosis transmembrane conductance regulator
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
- MUC:
-
mucin
- PanIN:
-
pancreatic intraepithelial neoplasm
- PGK:
-
phosphoglycerol kinase
- siRNA:
-
short interfering ribonucleic acid
- SMC:
-
sialo–mucin complex
- UTR:
-
untranslated region
References
Abraham EH, Vos P, Kahn J, Grubman SA, Jefferson DM, Ding I et al. (1996). Nat Med 2: 593–596.
Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA et al. (2001). Clin Cancer Res 7: 4033–4040.
Bardeesy N, DePinho RA . (2002). Nat Rev Cancer 2: 897–909.
Breuer W, Glickstein H, Kartner N, Riordan JR, Ausiello DA, Cabantchik IZ . (1993). J Biol Chem 268: 13935–13939.
Buisine MP, Devisme L, Degand P, Dieu MC, Gosselin B, Copin MC et al. (2000). J Histochem Cytochem 48: 1667–1676.
Buisine MP, Devisme L, Savidge TC, Gespach C, Gosselin B, Porchet N et al. (1998). Gut 43: 519–524.
Cafferata EG, Gonzalez-Guerrico AM, Giordano L, Pivetta OH, Santa-Coloma TA . (2000). Biochim Biophys Acta 1500: 241–248.
Cafferata EG, Guerrico AM, Pivetta OH, Santa-Coloma TA . (2001). J Biol Chem 276: 15441–15444.
Chen R, Lim JH, Jono H, Gu XX, Kim YS, Basbaum CB et al. (2004). Biochem Biophys Res Commun 324: 1087–1094.
Choudhury A, Singh RK, Moniaux N, El-Metwally TH, Aubert JP, Batra SK . (2000). J Biol Chem 275: 33929–33936.
Davenport SE, Mergey M, Cherqui G, Boucher RC, Gespach C, Gabriel SE . (1996). Biochem Biophys Res Commun 229: 663–672.
Debailleul V, Laine A, Huet G, Mathon P, d'Hooghe MC, Aubert JP et al. (1998). J Biol Chem 273: 881–890.
Dhakshinamoorthy S, Jaiswal AK . (2002). Oncogene 21: 5301–5312.
Drumm ML, Pope HA, Cliff WH, Rommens JM, Marvin SA, Tsui LC et al. (1990). Cell 62: 1227–1233.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . (2001). Nature 411: 494–498.
Estell K, Braunstein G, Tucker T, Varga K, Collawn JF, Schwiebert LM . (2003). Mol Cell Biol 23: 594–606.
Gonzalez-Guerrico AM, Cafferata EG, Radrizzani M, Marcucci F, Gruenert D, Pivetta OH et al. (2002). J Biol Chem 277: 17239–17247.
Guo RJ, Huang E, Ezaki T, Patel N, Sinclair K, Wu J et al. (2004). J Biol Chem 279: 36865–36875.
Hinojosa-Kurtzberg AM, Johansson ME, Madsen CS, Hansson GC, Gendler SJ . (2003). Am J Physiol Gastrointest Liver Physiol 284: G853–G862.
Hokari R, Lee H, Crawley SC, Yang SC, Gum Jr JR, Miura S et al. (2005). Am J Physiol Gastrointest Liver Physiol 289: G949–G959.
Hruban RH, Goggins M, Parsons J, Kern SE . (2000). Clin Cancer Res 6: 2969–2972.
Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K et al. (2003). Cancer Res 63: 8614–8622.
Jepson S, Komatsu M, Haq B, Arango ME, Huang D, Carraway CA et al. (2002). Oncogene 21: 7524–7532.
Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF et al. (2003). Biochem Biophys Res Commun 305: 598–604.
Komatsu M, Jepson S, Arango ME, Carothers Carraway CA, Carraway KL . (2001). Oncogene 20: 461–470.
Komatsu M, Tatum L, Altman NH, Carothers Carraway CA, Carraway KL . (2000). Int J Cancer 87: 480–486.
Komatsu M, Yee L, Carraway KL . (1999). Cancer Res 59: 2229–2236.
Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX . (2001). Gut 48: 70–74.
Malmberg EK, Noaksson KA, Phillipson M, Johansson ME, Hinojosa-Kurtzberg M, Holm L et al. (2006). Am J Physiol Gastrointest Liver Physiol (in press) [Epub ahead of print].
Mariette C, Perrais M, Leteurtre E, Jonckheere N, Hemon B, Pigny P et al. (2004). Biochem J 377: 701–708.
McWilliams R, Highsmith WE, Rabe KG, de AM, Tordsen LA, Holtegaard LM et al. (2005). Gut 54: 1661–1662.
Namkung W, Lee JA, Ahn W, Han W, Kwon SW, Ahn DS et al. (2003). J Biol Chem 278: 200–207.
Neglia JP, FitzSimmons SC, Maisonneuve P, Schoni MH, Schoni-Affolter F, Corey M et al. (1995). N Engl J Med 332: 494–499.
Park HU, Kim JW, Kim GE, Bae HI, Crawley SC, Yang SC et al. (2003). Pancreas 26: e48–e54.
Perrais M, Pigny P, Ducourouble MP, Petitprez D, Porchet N, Aubert JP et al. (2001). J Biol Chem 276: 30923–30933.
Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z et al. (1989). Science 245: 1066–1073.
Schoumacher RA, Ram J, Iannuzzi MC, Bradbury NA, Wallace RW, Hon CT et al. (1990). Proc Natl Acad Sci USA 87: 4012–4016.
Sheldon CD, Hodson ME, Carpenter LM, Swerdlow AJ . (1993). Br J Cancer 68: 1025–1028.
Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK . (2004). Cancer Res 64: 622–630.
Soto P, Price-Schiavi SA, Carraway KL . (2003). J Biol Chem 278: 20338–20344.
Steagall WK, Elmer HL, Brady KG, Kelley TJ . (2000). Am J Respir Cell Mol Biol 22: 45–50.
Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL et al. (2002). Am J Clin Pathol 117: 791–796.
Tabary O, Escotte S, Couetil JP, Hubert D, Dusser D, Puchelle E et al. (1999). Am J Pathol 155: 473–481.
Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, Domino SE, Lowe JB, Gendler SJ et al. (2002). Biochem J 367: 609–616.
Uribe JM, McCole DF, Barrett KE . (2002). Am J Physiol Gastrointest Liver Physiol 283: G923–G931.
Warren N, Holmes JA, al-Jader L, West RR, Lewis DC, Padua RA . (1991). BMJ 302: 760–761.
Welsh MJ, Smith AE . (1993). Cell 73: 1251–1254.
Winpenny JP, McAlroy HL, Gray MA, Argent BE . (1995). Am J Physiol 268: C823–C828.
Zielenski J, Tsui LC . (1995). Annu Rev Genet 29: 777–807.
Acknowledgements
We thank Erik Moore for technical support and the Molecular Biology Core Facility for oligonucleotide synthesis and DNA sequencing. We also thank Dr Parmender Mehta (Department of Biochemistry and Molecular Biology) and Dr Rakesh Singh (Department of Pathology and Microbiology) at University of Nebraska Medical Center for critical reading of the manuscript. This work was supported, in part, by an R01 grant CA78590 from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, A., Chauhan, S., Andrianifahanana, M. et al. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene 26, 30–41 (2007). https://doi.org/10.1038/sj.onc.1209764
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209764
Keywords
This article is cited by
-
Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers
Cancer and Metastasis Reviews (2019)
-
Cystic fibrosis transmembrane conductance regulator—emerging regulator of cancer
Cellular and Molecular Life Sciences (2018)
-
miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer
Oncogene (2015)
-
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer
Oncogene (2013)
-
Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades
Molecular Cancer (2012)